Rutgers University: New COVID-19 Drug Shows Greater Promise Against Resistant Viral Strains
April 03, 2025
April 03, 2025
NEW BRUNSWICK, New Jersey, April 3 -- Rutgers University issued the following news:
* * *
New COVID-19 Drug Shows Greater Promise Against Resistant Viral Strains
By Andrew Smith
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.
As with its predecessor, the new drug candidate, Jun13296, targets a dif . . .
* * *
New COVID-19 Drug Shows Greater Promise Against Resistant Viral Strains
By Andrew Smith
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.
As with its predecessor, the new drug candidate, Jun13296, targets a dif . . .